Performance of 18Fluorodeoxyglucose-Positron Emission Tomography and Somatostatin Receptor Scintigraphy for High Ki67 (≥10%) Well-Differentiated Endocrine Carcinoma Staging

Ronan Abgral; Sophie Leboulleux; Désirée Déandreis; Anne Aupérin; Jean Lumbroso; Clarisse Dromain; Pierre Duvillard; Dominique Elias; Thierry de Baere; Jo?l Guigay; Michel Ducreux; Martin Schlumberger; Eric Baudin

首页> 外文期刊>The journal of clinical endocrinology and metabolism >Performance of 18Fluorodeoxyglucose-Positron Emission Tomography and Somatostatin Receptor Scintigraphy for High Ki67 (≥10%) Well-Differentiated Endocrine Carcinoma Staging

【24h】

Performance of 18Fluorodeoxyglucose-Positron Emission Tomography and Somatostatin Receptor Scintigraphy for High Ki67 (≥10%) Well-Differentiated Endocrine Carcinoma Staging

机译：18氟脱氧葡萄糖正电子发射断层显像和生长抑素受体闪烁显像在高分化Ki67（≥10％）高分化内分泌癌分期中的表现

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective:The purpose of this prospective study was to compare the performance of ~(111)In-octreotide somatostatin receptor scintigraphy (SRS) and ~(18)fluorodesoxyglucose positron emission tomography (FDG-PET) in aggressive well-differentiated endocrine carcinoma (WDEC) defined by a high Ki67 (≥10%).

机译：目的：这项前瞻性研究的目的是比较〜（111）-奥曲肽生长抑素受体闪烁体显像（SRS）和〜（18）氟脱氧葡萄糖正电子发射断层显像（FDG-PET）在侵袭性高分化内分泌癌（WDEC）中的表现）定义为高Ki67（≥10％）。

著录项

来源
《The journal of clinical endocrinology and metabolism》 |2011年第3期|共7页
作者
Ronan Abgral; Sophie Leboulleux; Désirée Déandreis; Anne Aupérin; Jean Lumbroso; Clarisse Dromain; Pierre Duvillard; Dominique Elias; Thierry de Baere; Jo?l Guigay; Michel Ducreux; Martin Schlumberger; Eric Baudin;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. Staging of digestive endocrine tumours using helical computed tomography and somatostatin receptor scintigraphy. [J] . Panzuto F, Falconi M, Nasoni S, Annals of oncology: official journal of the European Society for Medical Oncology . 2003,第4期

机译：使用螺旋计算机断层扫描和生长抑素受体闪烁显像技术对消化内分泌肿瘤进行分期。
2. Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67. [J] . Belhocine T, Foidart J, Rigo P, Nuclear Medicine Communications . 2002,第8期

机译：氟脱氧葡萄糖正电子发射断层显像和生长抑素受体闪烁显像技术用于类癌的诊断和分期：与病理指标p53和Ki-67的相关性。
3. Somatostatin receptor scintigraphy and chromogranin A assay in staging and follow-up of patients with well-differentiated neuroendocrine tumors. [J] . Stokkel MP, Rietbergen DD, Korse CM, Nuclear Medicine Communications . 2011,第8期

机译：生长抑素受体闪烁显像法和嗜铬粒蛋白A分析法对分化良好的神经内分泌肿瘤患者的分期和随访。
4. 99mTc-EDDA-Tricine-HYNIC-TOC versus 99mTc-EDDA-Tricine-HYNIC-TATE: Synthesis and Preclinical Result of Two NewRadiopharmaceuticals for Somatostatin Receptor Scintigraphy [C] . M.Gandomkar, R.Najafi, M.Rabbani Trends in Radiopharmaceuticals(ISTR-2005) . 2007

机译：99mTc-EDDA-Tricine-HYNIC-TOC与99mTc-EDDA-Tricine-HYNIC-TATE：两种生长抑素受体显像新药的合成及临床前结果
5. Utilizing Positron Emission Tomography to Detect Functional Changes Following Drug Therapy in a Renal Cell Carcinoma Mouse Model. [D] . Chapman, David William. 2013

机译：利用正电子发射断层扫描来检测肾细胞癌小鼠模型中药物治疗后的功能变化。
6. A Family with Von Hippel-Lindau Syndrome: The Findings of Indium-111 Somatostatin Receptor Scintigraphy Iodine-123 Metaiodobenzylguanidine Scintigraphy and Single Photon Emission Computerized Tomography [O] . Pelin Arıcan, Berna Okudan Tekin, Seniha Naldöken, 2017

机译：冯·希佩尔-林道综合征的家庭：铟111生长抑素受体闪烁显像碘123碘碘苄基胍闪烁显像和单光子发射计算机断层扫描的发现。
7. Performance of 18Fluorodeoxyglucose-Positron Emission Tomography and Somatostatin Receptor Scintigraphy for High Ki67 (≥10) Well-Differentiated Endocrine Carcinoma Staging [O] . Ronan Abgral, Sophie Leboulleux, Désirée Déandreis, 2011

机译：18氟二氢葡萄糖 - 正电子发射断层扫描和高ki67（≥10％）良好分化的内分泌癌分期的尖锐菌断层扫描和生长抑素受体闪烁的性能

Performance of 18Fluorodeoxyglucose-Positron Emission Tomography and Somatostatin Receptor Scintigraphy for High Ki67 (≥10%) Well-Differentiated Endocrine Carcinoma Staging

摘要

著录项

相似文献

相关主题

期刊订阅